Article Details
Retrieved on: 2024-06-21 16:08:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Based on these data, the FDA has granted MB-106 orphan drug status and [regenerative medicine advanced therapy] designation for the treatment of ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here